A study led by ICREA researcher Salvador Aznar Benitah and undertaken at the Institute for Research in Biomedicine (IRB Barcelona) based at PCB has identified two proteins that are fundamental to conserve skin stem cells and has shown that without these proteins these cells are lost. The study, which has been published in Cell Stem Cell, has involved Luciano Di Croce’s group at the Center for Genomic Regulation (CRG).
The welcome ceremony to participants of the Spend the summer at the Park! program was held tyesterday, Monday, July 18. The aim of this initiative –organized annually by the Barcelona Science Park (PCB)– is to bring research closer to students of any university in the world through their participation in projects currently being carried out in research groups, research centers and companies based at the PCB.
This morning in Barcelona, the Institute for Research in Biomedicine (IRB Barcelona) –based at Barcelona Science Park (PCB)– and the Barcelona Supercomputing Center-National Supercomputing Center (BSC-CNS) have presented Nostrum Biodiscovery, a new biotech company that applies computational simulation to help new drugs and biotech molecules to reach the market. The creation of this spin-off has also been made possible thanks to the Bosch i Gimpera Foundation (FBG) of the University of Barcelona (UB) and the Catalan Institute for Research and Advanced Studies (ICREA), with the support by the Botín Foundation’s technology transfer programme.
Avizorex Pharma –an ophthalmology biotech company with offices at Barcelona Science Park (PCB)– announces the submission of a Clinical Trial Application (CTA) to the Spanish Competent Authority, requesting clearance to initiate a Phase I/II clinical trial investigating the use of AVX-012 Ophthalmic Solution, a small molecule with a novel mechanism of action to treat patients suffering from mild to moderate Dry Eye Syndrome (DES).
A team of researchers from the Centro Nacional de Análisis Genómico (CNAG-CRG) –based at the Barcelona Science Park (PCB)–, the Centre for Genomic Regulation (CRG) in Barcelona, and the Real Jardin Botánico (CSIC-RJB) in Madrid, has brought new insight to the genetic puzzle of the olive tree, by sequencing the complete genome of this species for the first time ever. The results of this work, published this week in the groundbreaking Open Access and Open Data journal GigaScience, will facilitate genetic improvement for production of olives and olive oil, two key products in the Spanish economy and diet.
Xavier Salvatella, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) at PCB, in collaboration with scientists from the University of Florence (Italy), has described a molecular system of protection that involves the androgen receptor protein, a molecule that is mutated in patients with Kennedy’s disease and which cause progressive muscle wastage.
The Barcelona Science Park (PCB) just opened the call to participate at the 12th edition of BATX2LAB, a tutoring program for secondary school students who undertake research projects. The initiative is part of the Research in Society program -organized by PCB´s Science Outreach Division- that offers around 80 activities addressed at different audiences from a wide age range with a participation of over 4,5000 people each year.
Two translational research studies published in the high impact scientific magazines Journal of Allergy and Clinical Immunology and Journal of Investigative Dermatology have described new immunologic mechanisms in psoriasis, a chronic cutaneous inflammatory disease which affects around the 2% of the population. The studies have been led by Lluís Francesc Santamaria, Director of the group of Translationary Immunology of the University of Barcelona (UB) based at the Barcelona Science Park, together with researchers of the Hospital del Mar and the Municipal Institute for Medical Research, among others.
Mind the Byte and Sequentia Biotech, both based at the Barcelona Science Park (PCB), have been two of the 10 Catalan companies that participated last week in a trade mission in the state of Massachusetts (US) to search for business opportunities in the fields of digital health and big data applied to life sciences. The trade mission was organized by the Government of Catalonia through ACCIÓ, the agency for business competitiveness, and Biocat coinciding with Bio-IT World Conference & Expo, one of the largest and most important events in the US in the field of ICTs in the health sector.
The Catalan Association of Biotech Companies, CataloniaBio, has joined efforts with the Richi Foundation, an international foundation with headquarters in Boston with the mission to improve the diagnosis and quality of life of children with cancer.
